|
1
|
Lwin Z, MacFadden D, Al-Zahrani A, Atenafu
E, Miller BA, Sahgal A, Menard C, Laperriere N and Mason WP:
Glioblastoma management in the temozolomide era: have we improved
outcome? J Neurooncol. 115:303–310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Julka PK, Sharma DN, Mallick S, Gandhi AK,
Joshi N and Rath GK: Postoperative treatment of glioblastoma
multiforme with radiation therapy plus concomitant and adjuvant
temozolomide: A mono-institutional experience of 215 patients. J
Cancer Res Ther. 9:381–386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alnaami IM, Al-Nuaimi SK, Senthilselvan A,
Murtha AD, Walling S, Mehta V and Gourishankar S: Effectiveness of
adjuvant temozolomide treatment in patients with glioblastoma.
Neurosciences (Riyadh). 18:349–355. 2013.
|
|
4
|
Bocangel DB, Finkelstein S, Schold SC,
Bhakat KK, Mitra S and Kokkinakis DM: Multifaceted resistance of
gliomas to temozolomide. Clin Cancer Res. 8:2725–2734.
2002.PubMed/NCBI
|
|
5
|
Lavon I, Fuchs D, Zrihan D, Efroni G,
Zelikovitch B, Fellig Y and Siegal T: Novel mechanism whereby
nuclear factor kappaB mediates DNA damage repair through regulation
of O (6)-methylguanine-DNA-methyltransferase. Cancer Res.
67:8952–8959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baldwin AS Jr: The NF-kappaB and I kappaB
proteins: new discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar
|
|
7
|
Mattioli I, Sebald A, Bucher C, et al:
Transient and selective NF-kappaB p65 serine 536 phosphorylation
induced by T cell costimulation is mediated by I kappaB kinase beta
and controls the kinetics of p65 nuclear import. J Immunol.
172:6336–6344. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang H, Lin H, Zhang X and Li J:
Resveratrol reverses temozolomide resistance by downregulation of
MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
Oncol Rep. 27:2050–2056. 2012.PubMed/NCBI
|
|
9
|
Gupta SC, Patchva S, Koh W and Aggarwal
BB: Discovery of curcumin, a component of golden spice and its
miraculous biological activities. Clin Exp Pharmacol Physiol.
39:283–299. 2012. View Article : Google Scholar :
|
|
10
|
Shakibaei M, Mobasheri A, Lueders C, Busch
F, Shayan P and Goel A: Curcumin enhances the effect of
chemotherapy against colorectal cancer cells by inhibition of NF-κB
and Src protein kinase signaling pathways. PLoS One. 8:e572182013.
View Article : Google Scholar
|
|
11
|
Orr WS, Denbo JW, Saab KR, et al: Curcumin
potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB
activity. PLoS One. 8:e513092013. View Article : Google Scholar
|
|
12
|
Dhandapani KM, Mahesh VB and Brann DW:
Curcumin suppresses growth and chemoresistance of human
glioblastoma cells via AP-1 and NFkappaB transcription factors. J
Neurochem. 102:522–538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramachandran C, Nair SM, Escalon E and
Melnick SJ: Potentiation of etoposide and temozolomide cytotoxicity
by curcumin and turmeric force in brain tumor cell lines. J
Complement Integr Med9:. Article. 20:2012.
|
|
14
|
Fabbri M: MicroRNAs and cancer: towards a
personalized medicine. Curr Mol Med. 13:751–756. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Williams AE: Functional aspects of animal
microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar
|
|
16
|
Sha M, Ye J, Zhang LX, Luan ZY and Chen
YB: Celastrol induces apoptosis of gastric cancer cells by miR-146a
inhibition of NF-κB activity. Cancer Cell Int. 13:502013.
View Article : Google Scholar
|
|
17
|
Crone SG, Jacobsen A, Federspiel B,
Bardram L, Krogh A, Lund AH and Friis-Hansen L: microRNA-146a
inhibits G protein-coupled receptor-mediated activation of NF-κB by
targeting CARD10 and COPS8 in gastric cancer. Mol Cancer.
11:712012. View Article : Google Scholar
|
|
18
|
Bao B, Ali S, Banerjee S, et al: Curcumin
analogue CDF inhibits pancreatic tumor growth by switching on
suppressor microRNAs and attenuating EZH2 expression. Cancer Res.
72:335–345. 2012. View Article : Google Scholar
|
|
19
|
Park MH, Ahn BH, Hong YK and Min do S:
Overexpression of phospholipase D enhances matrix
metalloproteinase-2 expression and glioma cell invasion via protein
kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling
pathways. Carcinogenesis. 30:356–365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
21
|
Agrawal DK and Mishra PK: Curcumin and its
analogues: potential anticancer agents. Med Res Rev. 30:818–860.
2010.
|
|
22
|
Goel A and Aggarwal BB: Curcumin, the
golden spice from Indian saffron, is a chemosensitizer and
radiosensitizer for tumors and chemoprotector and radioprotector
for normal organs. Nutr Cancer. 62:919–930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chainani-Wu N: Safety and
anti-inflammatory activity of curcumin: a component of tumeric
(Curcuma longa). J Altern Complement Med. 9:161–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zanotto-Filho A, Braganhol E, Edelweiss
MI, et al: The curry spice curcumin selectively inhibits cancer
cells growth in vitro and in preclinical model of glioblastoma. J
Nutr Biochem. 23:591–601. 2012. View Article : Google Scholar
|
|
25
|
Aoki H, Takada Y, Kondo S, Sawaya R,
Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the
growth of malignant gliomas in vitro and in vivo through induction
of autophagy: role of Akt and extracellular signal-regulated kinase
signaling pathways. Mol Pharmacol. 72:29–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koshkin PA, Chistiakov DA and Chekhonin
VP: Role of microRNAs in mechanisms of glioblastoma resistance to
radio- and chemotherapy. Biochemistry (Mosc). 78:325–334. 2013.
View Article : Google Scholar
|
|
27
|
Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li
CH and Leung GK: MicroRNA-21 inhibition enhances in vitro
chemosensitivity of temozolomide-resistant glioblastoma cells.
Anticancer Res. 32:2835–2841. 2012.PubMed/NCBI
|
|
28
|
Ujifuku K, Mitsutake N, Takakura S, et al:
miR-195, miR-455-3p and miR-10a (*) are implicated in acquired
temozolomide resistance in glioblastoma multiforme cells. Cancer
Lett. 296:241–248. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mei J, Bachoo R and Zhang CL:
MicroRNA-146a inhibits glioma development by targeting Notch1. Mol
Cell Biol. 31:3584–3592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pogribny IP, Filkowski JN, Tryndyak VP,
Golubov A, Shpyleva SI and Kovalchuk O: Alterations of microRNAs
and their targets are associated with acquired resistance of MCF-7
breast cancer cells to cisplatin. Int J Cancer. 127:1785–1794.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Atkinson GP, Nozell SE and Benveniste ET:
NF-kappaB and STAT3 signaling in glioma: targets for future
therapies. Expert Rev Neurother. 10:575–586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fukushima T, Kawaguchi M, Yorita K, et al:
Antitumor effect of dehydroxymethylepoxyquinomicin, a small
molecule inhibitor of nuclear factor-κB, on glioblastoma. Neuro
Oncol. 14:19–28. 2012. View Article : Google Scholar :
|
|
33
|
Brassesco MS, Roberto GM, Morales AG, et
al: Inhibition of NF-κB by dehydroxymethylepoxyquinomicin
suppresses invasion and synergistically potentiates temozolomide
and γ-radiation cytotoxicity in glioblastoma cells. Chemother Res
Pract. 2013:5930202013.
|
|
34
|
Paik JH, Jang JY, Jeon YK, et al:
MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and
functions as a tumor suppressor having strong prognostic
implications in NK/T cell lymphoma. Clin Cancer Res. 17:4761–4771.
2011. View Article : Google Scholar : PubMed/NCBI
|
